EVENITY® Risk Minimisation Materials Effectiveness Measurement in Australia (20220120)

13/04/2023
13/05/2024
EU PAS number:
EUPAS104308
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

Protocol-Published Original romosozumab 20220120 (1).pdf

English (353.09 KB - PDF) View document
Study results
Study report
Study report

20220120_ORSR_Abstract_Redacted.pdf

English (1.78 MB - PDF) View document
Other information